OP28 A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)

M. Truyens, T. Lobaton, A. Peeters, M. Ferrante, S. Vermeire, P. Bossuyt, L. Pouillon, P. Dewint, A. Cremer, H. Peeters, G. Lambrecht, E. Louis, J.F. Rahier, O. Dewit, V. Muls, T. Holvoet, L. Vandermeulen, G.B. Gonzales, D. Laukens, M. De Vos

Research output: Contribution to journalAbstractAcademic

Abstract


Original languageEnglish
Pages (from-to)i029-i032
JournalJournal of Crohn's and Colitis
Volume16
Issue numberSupplement_1
DOIs
Publication statusPublished - 21 Jan 2022
Event17th Congress of ECCO - European Crohn's and Colitis Organisation (2022) - Virtual
Duration: 16 Feb 202219 Feb 2022

Fingerprint

Dive into the research topics of 'OP28 A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)'. Together they form a unique fingerprint.

Cite this